Cultivating a career in specialty pharmacy has never been more exciting.
Necessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.
The financial consequences of becoming disabled can be devastating if pharmacists lack proper financial planning.
Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
The effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.
Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
Differences in formulary coverage of antihypertensive medications for children between private and public insurance plans may impact physician prescribing practices and patient outcomes.
A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.
Many patients face significant challenges in accessing their specialty medications, which highlights the importance of pharmacy-deployed patient navigation programs designed to help resolve nonclinical, system-related barriers to care.
While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
There are a multitude of reasons why pharmacy students choose to pursue a career in specialty pharmacy.
As medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers
Ms.Wawrzyn is the Norris Health CenterPharmacy Manager and the Introduction to the Practice of Pharmacy Course Instructor at the University of Wisconsin-Milwaukee.
SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.
Opioids are associated with various adverse effects, including constipation, nausea, respiratory depression, sedation, and vomiting.
The FDA approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism following hip or knee replacements and for the prevention of stroke in patients with nonvalvular atrial fibrillation.
The combination of brentuximab vedotin (Adcetris) and nivolumab (Opdivo) found to be active and safe in relapsed/refractory classical Hodgkin lymphoma.
A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
As is the case with any service-driven industry, the need to continually assess end-user satisfaction is paramount.
Colorado legislature enacts price caps of $100 per month for products and authorizes attorney general to investigate pricing.
The FDA has expanded the use of the powerful painkiller oxycodone (OxyContin) for children as young as 11.
Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.
As a majority of advanced pharmacy practice experiences need to include direct patient care, immunizing provides students an opportunity to provide this care along with consultation around the COVID-19 vaccine and adverse effects.
Proton pump inhibitors are cost-effective options for stress ulcer prophylaxis.
This issue of The American Journal of Pharmacy Benefts includes several articles about neurologic conditions and the medications used to treat them. We chose to focus on this area for 2 reasons.